Board Meetings for GUFICBIO

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
GUFICBIOGufic Biosciences Limited29 May 2026Financial Results/Dividend/Other business mattersTo consider and approve, inter alia, the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and financial year ended March 31, 2026, dividend and other business matters
GUFICBIOGufic Biosciences Limited29 May 2026Board Meeting IntimationGUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend/Other business.
GUFICBIOGufic Biosciences Limited13 Feb 2026Board Meeting IntimationGufic Biosciences Limited has informed the Exchange about Board Meeting to be held on 13-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business.
GUFICBIOGufic Biosciences Limited13 Feb 2026Financial Results/Other business mattersTo consider and approve Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine months ended December 31, 2025 and other business matters
GUFICBIOGufic Biosciences Limited14 Nov 2025Board Meeting IntimationGUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2025 and Other business.
GUFICBIOGufic Biosciences Limited14 Nov 2025Financial Results/Other business mattersTo consider and approve the Unaudited financial results for the Quarter and half year ended September 30, 2025 and other business matters
GUFICBIOGufic Biosciences Limited13 Aug 2025Board Meeting IntimationGUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 13-Aug-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2025 and Other business.
GUFICBIOGufic Biosciences Limited13 Aug 2025Financial Results/Other business mattersTo consider and approve the unaudited financial results for the quarter ended Jun 30, 2025 and other business matters
GUFICBIOGufic Biosciences Limited30 May 2025Board Meeting IntimationGUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend/Other business.
GUFICBIOGufic Biosciences Limited30 May 2025Financial Results/Dividend/Other business mattersTo consider and approve, inter alia, Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2025, and to recommend a final dividend, if any, for the Financial Year 2024-25.
GUFICBIOGufic Biosciences Limited14 Feb 2025Board Meeting IntimationGUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Other business.
GUFICBIOGufic Biosciences Limited14 Feb 2025Financial Results/Other business mattersTo consider and approve, inter alia, the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended December 31, 2024
GUFICBIOGufic Biosciences Limited14 Nov 2024Board Meeting IntimationGUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2024 and Other business.
GUFICBIOGufic Biosciences Limited14 Nov 2024Financial Results/Other business mattersTo consider and approve the financial results for the period ended September 30, 2024 and other business matters
GUFICBIOGufic Biosciences Limited14 Aug 2024Financial Results/Other business mattersTo consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2024 and other business matters
Showing page 1 of 9 (132 total items)
Next